Advanced search
Publication Cover
Renal Failure Volume 31, 2009 - Issue 8
Submit an article Journal homepage
1,249
Views
30
CrossRef citations to date
0
Altmetric
Clinical Studies

Superior Outcome of Nafamostat Mesilate as an Anticoagulant in Patients Undergoing Maintenance Hemodialysis with Intracerebral Hemorrhage

Jae Won Yang Department of Internal Medicine, Yonsei University Wonju College of Medicine
,
Byoung Geun Han Department of Internal Medicine, Yonsei University Wonju College of Medicine
,
Bi Ro Kim Department of Internal Medicine, Yonsei University Wonju College of Medicine
,
Yo Han Lee Department of Internal Medicine, Yonsei University Wonju College of Medicine
,
Young Sub Kim Department of Internal Medicine, Yonsei University Wonju College of Medicine
,
Jong Myeong Yu Department of Internal Medicine, Yonsei University Wonju College of Medicine
&
Seung Ok Choi Department of Internal Medicine, Yonsei University Wonju College of MedicineCorrespondence[email protected]
 show all
Pages 668-675 | Received 08 Apr 2009, Accepted 17 May 2009, Published online: 09 Oct 2009

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Riccardo Asero, Elena Pinter, Alessandro Maria Marra, Alberto Tedeschi, Massimo Cugno & Angelo Valerio Marzano. (2015) Current challenges and controversies in the management of chronic spontaneous urticaria. Expert Review of Clinical Immunology 11:10, pages 1073-1082.
Read now
Hidenobu Ochiai, Shigehiro Uezono, Hirokazu Kawano, Naoko Ikeda, Keiko Kodama & Hiroshi Akiyama. (2010) Factors affecting outcome of intracerebral hemorrhage in patients undergoing chronic hemodialysis. Renal Failure 32:8, pages 923-927.
Read now

Articles from other publishers (28)

Faeq Husain-Syed, Tomonori Takeuchi, Javier A. Neyra, Gonzalo Ramírez-Guerrero, Mitchell H. Rosner, Claudio Ronco & Ashita J. Tolwani. (2023) Acute kidney injury in neurocritical care. Critical Care 27:1.
Crossref
Shinya Kameda, Tomoko Fujii, Junpei Ikeda, Akira Kageyama, Toshishige Takagi, Naoki Miyayama, Kengo Asano, Arata Endo & Shoichi Uezono. (2023) Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study. BMC Nephrology 24:1.
Crossref
Yuheng Lang, Yue Zheng, Bingcai Qi, Weifeng Zheng, Jin Wei, Chengxiu Zhao, Wenqing Gao & Tong Li. (2022) Anticoagulation with nafamostat mesilate during extracorporeal life support. International Journal of Cardiology 366, pages 71-79.
Crossref
Mai J. Miyaji, Kentaro Ide, Kohei Takashima, Mikiko Maeno, Kelli A. Krallman, Danielle Lazear & Stuart L. Goldstein. (2022) Comparison of nafamostat mesilate to citrate anticoagulation in pediatric continuous kidney replacement therapy. Pediatric Nephrology 37:11, pages 2733-2742.
Crossref
Rupesh Raina, Ronith Chakraborty, Andrew Davenport, Patrick Brophy, Sidharth Sethi, Mignon McCulloch, Timothy Bunchman & Hui Kim Yap. (2021) Anticoagulation in patients with acute kidney injury undergoing kidney replacement therapy. Pediatric Nephrology 37:10, pages 2303-2330.
Crossref
Ji Yong Jung, Kyung Don Yoo, Eunjeong Kang, Hee Gyung Kang, Su Hyun Kim, Hyoungnae Kim, Hyo Jin Kim, Tae-Jin Park, Sang Heon Suh, Jong Cheol Jeong, Ji-Young Choi, Young-Hwan Hwang, Miyoung Choi, Yae Lim Kim & Kook-Hwan Oh. (2022) Executive summary of the Korean Society of Nephrology 2021 clinical practice guideline for optimal hemodialysis treatment. The Korean Journal of Internal Medicine 37:4, pages 701-718.
Crossref
Lukas Wettstein, Frank Kirchhoff & Jan Münch. (2022) The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment. International Journal of Molecular Sciences 23:3, pages 1351.
Crossref
Ji Yong Jung, Kyung Don Yoo, Eunjeong Kang, Hee Gyung Kang, Su Hyun Kim, Hyoungnae Kim, Hyo Jin Kim, Tae-Jin Park, Sang Heon Suh, Jong Cheol Jeong, Ji-Young Choi, Young-Hwan Hwang, Miyoung Choi, Yae Lim Kim & Kook-Hwan Oh. (2021) Executive Summary of the Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment. Kidney Research and Clinical Practice 40:4, pages 578-595.
Crossref
Ji Yong Jung, Kyung Don Yoo, Eunjeong Kang, Hee Gyung Kang, Su Hyun Kim, Hyoungnae Kim, Hyo Jin Kim, Tae-Jin Park, Sang Heon Suh, Jong Cheol Jeong, Ji-Young Choi, Young-Hwan Hwang, Miyoung Choi, Yae Lim Kim & Kook-Hwan Oh. (2021) Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment. Kidney Research and Clinical Practice 40:Suppl 1, pages S1-S37.
Crossref
Sergey V Zhuravel, Oleg K Khmelnitskiy, Oleg O Burlaka, Alexey I Gritsan, Boris M Goloshchekin, Seieun Kim & Ka Young Hong. (2021) Nafamostat in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomised Phase II clinical trial. eClinicalMedicine 41, pages 101169.
Crossref
Wei Zhang, Ming Bai, Yan Yu, Xiaolan Chen, Lijuan Zhao & Xiangmei Chen. (2021) Continuous renal replacement therapy without anticoagulation in critically ill patients at high risk of bleeding: A systematic review and meta‐analysis. Seminars in Dialysis 34:3, pages 196-208.
Crossref
Hiroki Ishii, Chiaki Miyoshi, Keiji Hirai, Junki Morino, Saori Minato, Shohei Kaneko, Katsunori Yanai, Momoko Matsuyama, Taisuke Kitano, Mitsutoshi Shindo, Akinori Aomatsu, Hiroshi Shimoyama, Haruhisa Miyazawa, Kiyonori Ito, Yuichiro Ueda, Yoshio Kaku, Taro Hoshino, Susumu Ookawara & Yoshiyuki Morishita. (2020) Induction of hemodialysis with an arteriovenous fistula in a patient with hemophilia A. CEN Case Reports 9:3, pages 225-231.
Crossref
GeorgeZaki Ghali & MichaelGeorge Zaki Ghali. (2020) Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia. Neural Regeneration Research 15:12, pages 2217.
Crossref
Hui‐Quan Duan, Qiu‐Li Wu, Xue Yao, Bao‐You Fan, Hong‐Yu Shi, Chen‐Xi Zhao, Yan Zhang, Bo Li, Chao Sun, Xiao‐Hong Kong, Xin‐Fu Zhou & Shi‐Qing Feng. (2018) Nafamostat mesilate attenuates inflammation and apoptosis and promotes locomotor recovery after spinal cord injury. CNS Neuroscience & Therapeutics 24:5, pages 429-438.
Crossref
Ju Yong Lim, Joon Bum Kim, Suk Jung Choo, Cheol Hyun Chung, Jae Won Lee & Sung Ho Jung. (2016) Anticoagulation During Extracorporeal Membrane Oxygenation; Nafamostat Mesilate Versus Heparin. The Annals of Thoracic Surgery 102:2, pages 534-539.
Crossref
Tadayuki Takata, Yohei Kokudo, Kodai Kume, Kazuyo Ikeda, Masaki Kamada, Tetsuo Touge, Kazushi Deguchi & Tsutomu Masaki. (2016) Dialysis-induced Subdural Hematoma in an Arachnoid Cyst Associated with Autosomal Dominant Polycystic Kidney Disease. Internal Medicine 55:15, pages 2065-2067.
Crossref
Riccardo Asero, Alberto Tedeschi, Angelo Valerio Marzano & Massimo Cugno. (2015) Coagulation in Chronic Urticaria. Current Treatment Options in Allergy 2:4, pages 287-293.
Crossref
A. Tedeschi, P. Kolkhir, R. AseroD. Pogorelov, O. Olisova, N. Kochergin & M. Cugno. (2014) Chronic urticaria and coagulation: pathophysiological and clinical aspects. Allergy 69:6, pages 683-691.
Crossref
Sang Taek LeeHeeyeon Cho. (2014) The Use of Nafamostat Mesilate as an Anticoagulant during Continuous Renal Replacement Therapy for Children with a High Risk of Bleeding. Journal of the Korean Society of Pediatric Nephrology 18:2, pages 98.
Crossref
Riccardo Asero, Alberto Tedeschi & Massimo Cugno. (2013) Treatment of Refractory Chronic Urticaria: Current and Future Therapeutic Options. American Journal of Clinical Dermatology 14:6, pages 481-488.
Crossref
Seun Deuk Hwang, Yu Kyung Hyun, Sung Jin Moon, Sang Choel Lee & Soo Young Yoon. (2013) Nafamostat Mesilate for Anticoagulation in Continuous Renal Replacement Therapy. The International Journal of Artificial Organs 36:3, pages 208-216.
Crossref
Norbert Lameire & John A Kellum. (2013) Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2). Critical Care 17:1, pages 205.
Crossref
Andrew Davenport. (2012) Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments. Pediatric Nephrology 27:10, pages 1869-1879.
Crossref
Naoto Morimoto, Soichiro Henmi, Masato Yoshida & Nobuhiko Mukohara. (2012) Cardiopulmonary bypass strategy with low-dose heparin and nafamostat mesilate in cardiac surgery: A safe option for patients with acute stroke. The Journal of Thoracic and Cardiovascular Surgery 144:3, pages 726-728.
Crossref
. (2012) References. Kidney International Supplements 2:1, pages 124-138.
Crossref
. (2012) Section 5: Dialysis Interventions for Treatment of AKI. Kidney International Supplements 2:1, pages 89-115.
Crossref
Andrew Davenport. (2011) What are the anticoagulation options for intermittent hemodialysis?. Nature Reviews Nephrology 7:9, pages 499-508.
Crossref
Sang Jin HanHyoung Soo KimKun Il KimSung Mi WhangKyung Soon HongWon Ki LeeSun Hee Lee. (2011) Use of Nafamostat Mesilate as an Anticoagulant during Extracorporeal Membrane Oxygenation. Journal of Korean Medical Science 26:7, pages 945.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.